1. Introduction {#sec1-molecules-21-00322}
===============

Allogeneic hematopoietic cell transplantation (HCT) has been developed to cure clonal disorder diseases, such as myelodysplastic syndromes (MDS) \[[@B1-molecules-21-00322],[@B2-molecules-21-00322]\]. Preclinical and limited clinical data suggest that iron overload related to anemia, red blood cell transfusions and, possibly other factors, may be associated with hepatic injury in patients undergoing HCT \[[@B1-molecules-21-00322],[@B3-molecules-21-00322]\]. Iron overload will lead to tissue damage and even iron poisoning because cells lack an effective way to dispose of the excessive iron. The liver is the major organ for iron storage and patients with chronic iron overload in the liver are at significantly higher risk of further developing liver fibrosis, cirrhosis, and hepatocellular carcinoma \[[@B4-molecules-21-00322]\].

Our previous work have shown that ferric ammonium citrate (FAC)-induced iron overload in HH4 cells was capable of increasing apoptosis through an iron-generated ROS-activated signaling pathway \[[@B5-molecules-21-00322]\], however the cellular consequences and process of iron overload in hepatocytes are still not very clear and need to be further elucidated. Therefore, the current study was aimed at assessing protein expression changes initiated by excess iron using a proteomic approach. We attempted to characterize the new "molecules" that are involved in inflammatory response induced by iron overload in HH4 cells. Our proteomics data revealed protein levels of Toll-like receptor 2 (TLR2) and IL6ST significantly increased seven times and 2.9 times, respectively, in iron overload HH4 cells. The subsequent results detected that FAC-treated HH4 cells can activate IL6 expression through TLR2-mediated inflammatory responses via NF-κB signaling pathway in HH4 cells.

2. Results {#sec2-molecules-21-00322}
==========

2.1. Overview of Proteomic Analysis (2D-LC-MS) {#sec2dot1-molecules-21-00322}
----------------------------------------------

To gain insight into the effect of FAC-induced iron overload on HH4 cells, 2D-LC-MS were carried out to compare the protein profiles of HH4 cells stimulated by FAC at concentrations of 0 and 5 mM, respectively. A total of 2502 unique proteins were identified in both of the two independent replicate experiments. Among these, expression of 58 proteins was higher (more than 1.5-fold) and expression of 35 proteins was lower (less than 0.67 fold) in FAC-treatment HH4 cells compared to untreated cells ([Figure 1](#molecules-21-00322-f001){ref-type="fig"}A and [Table 1](#molecules-21-00322-t001){ref-type="table"}). Next, we analyzed the main properties of these identified differentially expressed proteins using the Database for Annotation, Visualization and Integrated Discovery (DAVID) gene bioinformatic resources. The results showed these differentially expressed proteins are involved in various biological process mainly including response to wounding, di-, tri-valent inorganic cation homeostasis, regulation of growth, positive regulation of signal transduction, anti-apoptosis, inflammatory response, *etc.* ([Figure 1](#molecules-21-00322-f001){ref-type="fig"}B and [Table 2](#molecules-21-00322-t002){ref-type="table"}).

In addition, Gene Ontology (GO) analysis revealed that the most common molecular functions were purine nucleotide binding, ribonucleotide binding, adenyl nucleotide binding and identical protein binding ([Figure 1](#molecules-21-00322-f001){ref-type="fig"}C). On the other hand, the major cellular component categories were membrane-enclosed lumen, mitochondrion, golgi apparatus, endoplasmic reticulum and cell surface ([Figure 1](#molecules-21-00322-f001){ref-type="fig"}D). Subsequently, on the basis of KEGG pathways, we found that highly significant enrichment was seen in several pathways mainly including lysosome, hematopoietic cell lineage and drug metabolism ([Figure 1](#molecules-21-00322-f001){ref-type="fig"}E).

2.2. Analysis of Proteomics Data {#sec2dot2-molecules-21-00322}
--------------------------------

Next, we analyzed 93 differentially expressed proteins using Ingenuity Pathways Analysis (IPA) (Ingenuity Systems, Redwood, CA, USA, [www.ingenuity.com](www.ingenuity.com)). The metabolic and canonical pathways as well as the interconnecting proteins were generated.

The results showed that 13 proteins were involved in cell-to-cell signaling and interaction, inflammatory response and cellular movement pathway ([Figure 2](#molecules-21-00322-f002){ref-type="fig"}A). Twelve proteins were involved in cellular movement, inflammatory response and immune cell trafficking pathway ([Figure 2](#molecules-21-00322-f002){ref-type="fig"}B). These findings indicate that HH4 cell proteomes were markedly shifting after FAC overload treatment.

2.3. Validation of LC-MS/MS Results by RT-PCR {#sec2dot3-molecules-21-00322}
---------------------------------------------

In order to verify the accuracy of protein identifications made by LC-MS/MS, we randomly selected 11 proteins from 93 differentially expressed proteins to validate their mRNA levels. The results, as shown in [Figure 3](#molecules-21-00322-f003){ref-type="fig"}A, indicate when HH4 cells were treated with 5 mM FAC for 24 h, mRNA levels of gene IL6ST, APP, TF, TLR2, MME, TfR1 and CHCHD2 increased 1.7, 1.7, 13.6, 4.6, 3.1, 1.7, and 1.9 times, respectively compared to untreated HH4 cells. In addition, as shown in [Figure 3](#molecules-21-00322-f003){ref-type="fig"}B, the mRNA levels of GLG1, THBS1, EHD2 and CYP1B1 reduced 0.7, 0.3, 0.5 and 0.7 times, respectively in FAC-treated cells compared to untreated HH4 cells. Our findings are consistent with the results from proteomic mass spectroscopy.

2.4. FAC-Induced Iron Overload Affected Iron Homeostasis Related Proteins {#sec2dot4-molecules-21-00322}
-------------------------------------------------------------------------

After annotated the function of 93 differentially expressed proteins, we found the level of intracellular iron homeostasis related proteins increased significantly in FAC treated HH4 cells, such as IL6ST, TF and TfR1. It is well known that hepcidin is the center regulator to ensure iron metabolism in steady state. Therefore, we were interested in whether FAC-induced iron overload can affect expression of hepcidin and iron regulatory related proteins. As shown in [Figure 4](#molecules-21-00322-f004){ref-type="fig"}A, mRNA levels of gene TfR2, IL-6, STAT3, hepcidin and ferritin significantly increased after 24 h of exposure to 5 mM FAC in HH4 cells, suggesting FAC exposure facilitated TF-TfR2 and IL 6-STAT3 signaling pathway to further activate hepcidin expression ([Figure 4](#molecules-21-00322-f004){ref-type="fig"}B).

2.5. FAC Overload Triggered TLR2-Mediated Inflammatory Response {#sec2dot5-molecules-21-00322}
---------------------------------------------------------------

In the foregoing analysis via GO and IPA, we noticed that TLR2 was involved in FAC-induced iron overload in HH4 cells ([Figure 1](#molecules-21-00322-f001){ref-type="fig"}B, [Table 2](#molecules-21-00322-t002){ref-type="table"}, [Figure 2](#molecules-21-00322-f002){ref-type="fig"}A) and the mRNA level of TLR2 was also consistant with proteomics data ([Figure 3](#molecules-21-00322-f003){ref-type="fig"}A). We next investigated the protein level of TLR2 and its related pathway in FAC treated HH4 cells. As shown in [Figure 5](#molecules-21-00322-f005){ref-type="fig"}A, protein levels of TLR2 significantly increased in HH4 cells after 24 h of exposure to 5 mM FAC and its downstream factor, MyD88, was also significantly increased, indicating that FAC treatment activated the TLR2-MyD88 signaling pathway. In order to clarify the specific role of TLR2 in FAC treated hepatocytes, we next inhibited the endogenous TLR2 expression in HH4 cells using RNA interference.

As shown in [Figure 5](#molecules-21-00322-f005){ref-type="fig"}B, inhibition using siRNA significantly reduced protein levels of TLR2. In addition, inhibition of TLR2 markedly decreased the expression of IL-6 and IL6ST at transcriptional level in FAC-treated HH4 cells, compared to untreated cells ([Figure 5](#molecules-21-00322-f005){ref-type="fig"}C). Our data also indicated p-NF-κB but not p-p38 involving in activation of TLR2-IL6 pathway ([Figure 5](#molecules-21-00322-f005){ref-type="fig"}C,D).Taken together, these results suggested that TLR2-mediated inflammatory response triggered by FAC induced the expression of IL-6 through activating the NF-κB pathway rather than p38 pathway in HH4 cells.

3. Discussion {#sec3-molecules-21-00322}
=============

HCT is by far the most effective way to treat the clonal disorder disease \[[@B6-molecules-21-00322]\]. However, patients commonly have an increase of nontransferrin-bound iron (NTBI) and show hepatic iron overload already before HCT or after transplant conditioning \[[@B7-molecules-21-00322],[@B8-molecules-21-00322]\]. Excessive iron can stimulate the formation of ROS via the Fenton reaction \[[@B9-molecules-21-00322]\], and progressive accumulation of ROS may damage mitochondrial and nuclear DNA through lipid peroxidation \[[@B10-molecules-21-00322]\]. In our previous work, we have shown that iron overload can induce apoptosis via both extrinsic and intrinsic pathways in hepatic cells \[[@B5-molecules-21-00322]\]. To our knowledge, the exact cellular consequences and the cellular processes of iron overload in hepatocytes are still not very clear. In this current study, we utilized proteomics technique to dissect more signaling pathways that related to hepatocytes iron overload.

The mass spectrum results showed FAC-induced HH4 cells contained 93 differentially expressed proteins and activated multiple pathways ([Figure 1](#molecules-21-00322-f001){ref-type="fig"}A and [Table 1](#molecules-21-00322-t001){ref-type="table"}). Levels of protein ATP6V1H, which facilitates acidification of intracellular endosomes formed by transferrin/transferrin receptor-mediated endocytosis \[[@B11-molecules-21-00322],[@B12-molecules-21-00322]\], increased 1.6 times ([Table 1](#molecules-21-00322-t001){ref-type="table"}), while levels of protein EHD2, which plays an important role in regulating transferrin exit from ERC (endocytic recycling compartment) \[[@B13-molecules-21-00322]\], decreased three times ([Table 1](#molecules-21-00322-t001){ref-type="table"}) when HH4 cells were treated with 5 mM FAC at 24 h. These two significantly changed proteins indicate that HH4 cells may absorb a large number of extracellular iron ion via endocytosis.

Addition of excess iron inevitably led to iron dyshomeostasis and thus triggered differential expression of intracellular iron homeostasis associated proteins in HH4 cells ([Figure 1](#molecules-21-00322-f001){ref-type="fig"}B). Levels of protein TF (serotransferrin) which is mainly produced by hepatocytes and capable of binding excess iron ions and delivering it into cells increased sharply in FAC-overload HH4 cells ([Table 1](#molecules-21-00322-t001){ref-type="table"} and [Figure 3](#molecules-21-00322-f003){ref-type="fig"}A). Levels of protein IRP1, which is also known as cytoplasmic aconitate hydratase (ACO1), and is the trans-acting factor located in the cytoplasm that can bind with high affinity to RNA motifs related to iron homeostasis \[[@B14-molecules-21-00322]\], decreased 0.5 times ([Table 1](#molecules-21-00322-t001){ref-type="table"}) and levels of the protein ferritin, each molecule of which is capable of storing up to 4500 iron atoms \[[@B15-molecules-21-00322]\], increased 4.4 times ([Figure 4](#molecules-21-00322-f004){ref-type="fig"}A) in FAC- treated HH4 cells. Meanwhile, our MS data displayed the expression of γ-secretase C-terminal fragment 59 and amyloid-like protein 2 were increased 3.3-fold and 2.9-fold in FAC treated cells, respectively ([Table 1](#molecules-21-00322-t001){ref-type="table"}), suggesting that full length APP protein, which can stabilize surface FPN , may participate in the efflux of iron from HH4 cells \[[@B16-molecules-21-00322]\]. Our MS data also showed the expression of metallothionein-2 increased 1.8 times but SOD2 expression decreased 0.6 times in iron-loaded HH4 cells. Metallothioneins (MTs), which are conserved in the animal kingdom, can chelate heavy and trace metals such as zinc, copper or iron through sulfur-based clusters, and therefore the main function of MTs is the regulation of homeostasis, like the protection against oxidative stress or metals \[[@B17-molecules-21-00322]\]. While SOD2 (superoxide dismutase \[Mn\], mitochondrial) functioned as the antioxidant is known to scavenge the ROS, specifically the hydroxyl radical \[[@B18-molecules-21-00322]\]. In a word, these significantly changed proteins indicate that iron overload induces biological process of di-, tri-valent inorganic cation homeostasis in HH4 cells ([Figure 1](#molecules-21-00322-f001){ref-type="fig"}B and [Table 2](#molecules-21-00322-t002){ref-type="table"}).

In addition, hepcidin is undoubtedly the most central regulator of iron hemostasis, and our results also confirmed that FAC-induced HH4 cells showed evidently enhanced transcription levels of gene TF, TfR1/2, IL-6, IL6ST, STAT3 and hepcidin ([Figure 4](#molecules-21-00322-f004){ref-type="fig"}), indicating that hepcidin was involved in the re-regulation of iron homeostasis in iron overload-treated HH4 cells.

Mass spectral analysis also indicated the participation of other biological process including response to wounding, cell apoptosis and inflammatory response in FAC-induced HH4 cells. For example, thrombospondin-1 (THBS1) which is a matricellular glycoprotein first discovered in activated platelets that plays an important role in the process of wound healing \[[@B19-molecules-21-00322]\], decreased 0.47 times ([Table 1](#molecules-21-00322-t001){ref-type="table"} and [Figure 3](#molecules-21-00322-f003){ref-type="fig"}B), while the expression of endophilin-B1, which is involved in the regulation of apoptosis helping the maintenance of mitochondrial morphology and autophagy \[[@B20-molecules-21-00322]\], was apparently increased in HH4 cells after iron overload treatment ([Table 1](#molecules-21-00322-t001){ref-type="table"}). Among these, the most interestingly finding is the expression of inflammation mediator TLR2 increased markedly in FAC- treated HH4 cells ([Table 1](#molecules-21-00322-t001){ref-type="table"}). Inflammation is a fundamental biological process that stands at the foreground of acute and chronic pathological conditions \[[@B21-molecules-21-00322]\]. Toll-like receptors (TLRs) discovered in the 1990s are a family of very similar proteins containing leucine-rich repeats and their activation triggers a signaling cascade which leads to the production of cytokines/chemokines, further initiating an inflammatory response \[[@B22-molecules-21-00322]\]. So far 13 TLRs have been identified, 10 human TLRs (TLR1-10), and 12 mouse TLRs (TLR1-9, TLR11 and TLR12) \[[@B23-molecules-21-00322]\]. It is well known that the acute phase response to infection and inflammation can cause alterations in iron homeostasis, thereby reducing iron supplies to pathogens. A recent study found that the acute inflammatory condition mediated by TLR2 and TLR6 induced rapid hepcidin-independent hypoferremia through decreasing the messenger RNA and protein expression of ferroportin (FPN) in mice injected with TLR ligands \[[@B24-molecules-21-00322]\]. Although TLR2 has been implicated in the response to infection mediated by TLR2 ligands, includes molecules with diacyl and triacylglycerol moieties, proteins and polysaccharides, scanty data is available on the direct relationship between TLR2 and iron overload. Therefore, our next research validated TLR2 mRNA and protein expression in FAC treated HH4 cells ([Table 1](#molecules-21-00322-t001){ref-type="table"}, [Figure 3](#molecules-21-00322-f003){ref-type="fig"}A and [Figure 5](#molecules-21-00322-f005){ref-type="fig"}A), which is consistent with proteomics data. In addition, our experiment indicated that inhibition of TLR2 by siRNA inactivated IL-6 expression via NF-κB pathway in FAC treated hepatocytes ([Figure 5](#molecules-21-00322-f005){ref-type="fig"}).

4. Experimental Section {#sec4-molecules-21-00322}
=======================

4.1. Cell Culture {#sec4dot1-molecules-21-00322}
-----------------

The non-transformed human hepatocyte cell line HH4 was maintained as described previously \[[@B7-molecules-21-00322]\]. Briefly, HH4 cells were maintained in Williams' medium E (Gibco Laboratories, Grand Island, NY, USA), supplemented with 10% fetal bovine serum (FBS), 0.1% ITS, dexamethasone (0.04 μg/mL) (Sigma Chemical Co., St. Louis, MO, USA), gentamycin (50 μg/mL) (Sigma Chemical Co.), HEPES (20 mM) and sodium pyruvate (1 mM) (Gibco Laboratories).

4.2. In Vitro Iron Overload Model {#sec4dot2-molecules-21-00322}
---------------------------------

The *in vitro* iron overload model was established as previously described \[[@B5-molecules-21-00322]\]. Briefly, HH4 cells were seeded in 15 cm culture dishes at 1 × 10^5^ cells/mL, incubated overnight at 37 °C in 5% CO~2~ atmosphere, and then treated with or without 5 mM FAC (Sigma Chemical Co.) for 24 h. The experiments were repeated three times.

4.3. Proteomics Analysis {#sec4dot3-molecules-21-00322}
------------------------

### 4.3.1. Cell Lysis and Protein Digestion {#sec4dot3dot1-molecules-21-00322}

HH4 cells were washed three times with PBS buffer, harvested by trypsinization, and centrifuged at 1000× *g* for 5 min. After the addition of T-PER Reagent (Thermo Scientific, Rockford, CA, USA), PMSF (1 mM) and 0.1% aprotinin, the cell pellets were lysed for 30 min on ice and centrifuged at 13, 800× *g* for 15 min. Then the supernatant was transferred into new tubes. The Broadford assay was used to determine the protein concentration (Beyotime Institute of Biotechnology, Shanghai, China). Proteins were reduced with 10 mM dithiothreitol (DTT) at 56 °C for 45 min and then alkylated with 10 mM iodoacetamide (IAM) (Sigma Chemical Co.) for 20 min at room temperature in the dark. The sample was diluted four times with 40 mM ammonium bicarbonate buffer. Sequencing grade trypsin (Promega, Madison, WI, USA) was added in a 1:50 (*w*/*w*) ratio and the incubation was carried out overnight at 37 °C. After an over-night digestion peptides were recovered from the filter. Peptides were desalted with Oasis 1cc cartridges and flow through from Oasis cartridge was desalted with Sep-Pak C18 1cc (Waters, Milford, MA, USA). Elutions from Oasis and Sep-Pak were combined together and concentrated in SpeedVac.

### 4.3.2. Nanoflow LC-MS/MS {#sec4dot3dot2-molecules-21-00322}

Peptide digests dissolved in loading buffer (0.1% trifluoroacetic acid---TFA) were loaded onto an in-house packed 20 cm capillary column with 3 µm Reprosil-Pur C18 beads (Dr. Maisch GmbH, Ammerbuch, Germany) using an EASY-nLC 1000 system (Thermo Scientific). Running buffer A was 0.1% TFA in water and running buffer B was 0.1% TFA in ACN (acetonitrile). The total gradient was 120 min and the flow rate started at 300 nL/min. The detailed gradient was 6% ACN with a linear increase to 30% ACN over 105 min followed by 4 min linear increase to 90% ACN. MS data were acquired using a data-dependent top-20 method on Q Exactive (Thermo Scientific, Bremen, Germany). Spray voltage was set to 2.0 kV, S-lens RF level at 60, and capillary temperature at 275 °C. Full scan resolutions were set to 60,000 at *m*/*z* 200 and AGC (automatic gain control) was 3 × 10^6^ with a maximum fill time of 20 ms. The range of full mass was set to 350--1500 *m*/*z*. MS2 scan resolutions were set to 15,000 at *m*/*z* 200 and AGC was 5 × 10^4^ with a maximum fill time of 45 ms. Isolation width was set at 1.6 Th. A fixed first mass of 110 was used. Normalized collision energy was set at 27. Peptide match was set to "preferred" and isotope exclusion was on. Precursor ions with single, un-assigned, charge states were removed from fragmentation selection \[[@B25-molecules-21-00322],[@B26-molecules-21-00322],[@B27-molecules-21-00322]\].

### 4.3.3. Data Analysis {#sec4dot3dot3-molecules-21-00322}

All data were analyzed with the MaxQuant version 1.5.1.12 \[[@B28-molecules-21-00322]\], with the Andromeda search engine \[[@B29-molecules-21-00322]\]. The false discovery rate (FDR) was set at 1% for protein, peptide spectrum match. Peptides were required to have a minimum length of six amino acids and a maximum mass of 10,000 Da. Fragmentation spectra were searched by Andromeda in the Uniprot human database (version 201502; 90,300 entries) combined with 262 common contaminants \[[@B29-molecules-21-00322]\]. Enzyme specificity was set as C-terminal to arginine and lysine and a maximum of two missed cleavages. Second peptides search was enabled. For proteome identification, carbamidomethylation (C) was set as a fixed modification. deamidation (NQ) and oxidation (M) were set as variable modifications. To identify significantly regulated proteins, LFQ intensities were used. Proteins with *p*-value \< 0.05, fold change \> 1.5 or \< 0.67 were recognized as significant change.

4.4. Realtime-PCR {#sec4dot4-molecules-21-00322}
-----------------

Total RNA was extracted using RNA pure Tissue Kit (Cwbio, Beijing, China) according to the manufacturer's instruction. Real-time RT-PCR amplification was performed using an Ultra SYBR mixture kit (Cwbio) on the C1000 Touch Thermal Cycler (Bio-Rad, Hercules, CA, USA), and the results were analyzed using CFX Manager software (Bio-Rad). Target gene expression levels were quantified using the formula 2^−ΔΔct^ method \[[@B30-molecules-21-00322]\]. Primer sequences (Invitrogen Corporation, Shanghai, China) and optimal PCR annealing temperatures are listed in [Table 3](#molecules-21-00322-t003){ref-type="table"}.

4.5. Western Blot Analysis {#sec4dot5-molecules-21-00322}
--------------------------

Cells were lysed with RIPA (1% Triton X-100, 150 mM NaCl, 25 mM Tris pH 7.4, 5 mM EDTA, 0.5% sodium deoxycholate, 0.1% SDS, 5 mM tetrasodium pyrophosphate, 50 mM sodium fluoride, 1 mM Na~3~VO~4~, 2 mM phenylmethanesulfonyl fluoride, 0.076 U/mL aprotinin). After centrifugation at 13,800× *g* for 15 min, the supernatants were collected. Protein content was determined using BCA Protein Assay. Equal amounts of protein were subjected to SDS-PAGE. Proteins were electrophoretically transferred to PVDF membranes (Bio-Rad), and blocked with phosphate buffered saline/0.05% Tween-20 (PBS-T) containing 5% non-fat dry milk or BSA at room temperature (RT) for 1 h. Membranes were incubated with primary antibody TLR2, MyD88 (Abcam, Cambridge, MA, USA), p-p38 MAPK, p38 MAPK, p-NF-κB or NF-κB (Cell Signaling Technology, Boston, MA, USA) at a 1:1000 dilution in PBS-T at 4 °C overnight, washed four times with PBS-T, and then incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (Beyotime Institute of Biotechnology) in PBS-T at room temperature for 1 h. Protein was detected using an enhanced chemoluminiscence (ECL) kit (Tiangen, Beijing, China).

4.6. RNA Interference (RNAi) of Gene TLR2 {#sec4dot6-molecules-21-00322}
-----------------------------------------

For gene silencing assays, the small interfering RNA of TLR2 (siTLR2) gene and negative control siRNA (siNC) were synthesized by Invitrogen Corporation. The sense and anti-sense strands of siRNAs were: siRNA 1, 5′-GGUGAAACAAAUUCAUUGATT-3′ (sense), 5′-UCAAUGAAUUUGUUUCACCTT-3′ (antisense); siRNA 2, 5′-CCUCUCUACAAACUUUAAUTT-3′ (sense), 5′-AUUAAAGUUUGUAGAGAGGTT-3′ (antisense); siRNA 3, 5′-GCAACUCAAAGAACUUUAUTT-3′ (sense), 5′-AUAAAGUUCUUUGAGUUGCTT-3′ (antisense); hepatocytes were transiently transfected with oligofectamine according to the manufacturer's protocol in the presence or absence of 60 nM siRNA duplex. Western blot analysis of protein expression level of TLR2 was performed to identify inhibitory effect of siRNA in HH4 cell. After 48 h transfection with indicated siRNA, cells were treated with 5 mM FAC for 24 h and then the expression of a series of inflammation-related genes was detected using quantitative real-time RT-PCR or Western blot assay.

4.7. Statistical Analysis {#sec4dot7-molecules-21-00322}
-------------------------

Results were analyzed by one-way analysis of variance (ANOVA) or 2-sample unpaired *t*-test using Prism 5 program (Version 5.0). Differences in results were considered significant when *p* values were ≤ 0.05. Results are given as mean ± SEM of at least 3 independent experiments.

5. Conclusions {#sec5-molecules-21-00322}
==============

This is the first global proteomic analysis that compares the protein signatures of FAC-exposed HH4 cells with normal HH4 cells. Our study results suggest differentially expressed proteins are involved in multiple biological process including endocytosis, di-, tri-valent inorganic cation homeostasis, response to wounding, inflammatory response, anti-apoptosis, apoptotic mitochondrial changes and other processes. In addition, this work suggests for the first time that FAC overload can induce TLR2-mediated acute inflammatory response and activate IL6 expression via NF-κB pathways in HH4 cells. Our results should provide a theoretical basis for drug therapy of iron-associated liver damage.
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###### 

Differential proteomic analysis in HH4 cells. (**A**) Volcano plot of 2502 differentially expressed proteins between iron overload treatment group and control group in HH4 cells. (**B**--**D**) Functional classification of differentially expressed proteins using SWISS-PROT database based on universal GO annotation terms. Proteins shown were linked to at least one annotation term within the GO biological process (**B**); molecular function (**C**); and cellular component (**D**) categories; (**E**) KEGG pathway analysis.
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![Biological pathways analysis of differentially expressed proteins in HH4 cells. (**A**) Top network functions of cell-to-cell signaling and interaction, inflammatory response, cellular movement and (**B**) immune cell trafficking using Ingenuity Pathways Analysis (IPA). Solid lines: direct known interactions. Dashed lines: suspected or indirect interactions. White: proteins known to be in the network but not identified in our study.](molecules-21-00322-g002){#molecules-21-00322-f002}

![Confirmation of mass spectrometry-determined protein using RT-PCR technique. (**A**) Gene expression analysis of seven kinds of up-regulated proteins randomly selected from 93 kinds of differentially expressed proteins; (**B**) Gene expression analysis of four kinds of down-regulated proteins randomly selected from 93 kinds of differentially expressed proteins. The expression of genes was classified as up-regulated if expression levels were \>1.5-fold and as down-regulated if levels were \<0.67-fold, relative to control HH4 cells. Expression of β-actin was used as internal control. Results are shown as mean ± SEM of three independent experiments. Statistically significant differences are labeled as \* *p* \< 0.05 and \*\* *p* \< 0.01, compared with the control groups, using unpaired Student's *t* test.](molecules-21-00322-g003){#molecules-21-00322-f003}

![The effect of FAC overload on expression levels of iron homeostasis related gene. (**A**) FAC overload induced upregulation of iron homeostasis related protein expression. Expression of β-actin was used as internal control. Results are shown as mean ± SEM of three independent experiments. Statistically significant differences are labeled as \* *p* \< 0.05 and \*\* *p* \< 0.01, compared with the control groups, using unpaired Student's *t* test; (**B**) Schematic representation of the activation of Hepcidin regulation-associated signal transduction pathway in HH4 cells with FAC treatment.](molecules-21-00322-g004){#molecules-21-00322-f004}

![The activation of TLR2 pathway induced by iron overload in HH4 cells. (**A**) Protein expression of TLR2 and MyD88 were analyzed by western blot in HH4 cells after 24 h of 5 mM FAC treatment; (**B**) Inhibitory effects of siRNA for TLR2 in HH4 cells. Cells (10^5^ cells/well) were pre-treated with 60 nM siRNA for TLR2 for 48 h and then interference efficiency was estimated by detection of protein expression levels of TLR2 using western blot assay. NC = negative control siRNA; siRNA 1 = TLR2 siRNA (950 bp); siRNA 2 = TLR2 siRNA (1377 bp); siRNA 3 = TLR2 siRNA (1648 bp); (**C**) Effects of siRNA for TLR2 on transcriptional levels of IL-6 and IL6ST in HH4 cells. Cells (10^5^ cells/well) were pre-treated with 60 nM siRNA for TLR2 for 48 h. Then HH4 cells were treated with 5 mM FAC for 24 h and transcriptional levels of gene IL-6 and IL6ST via RT-PCR assay. Expression of β-actin was used as internal control. Results are shown as mean ± SEM of three independent experiments. Statistically significant differences are labeled as \*\* *p* \< 0.01 and \*\*\* *p* \< 0.001, compared with the control groups, using unpaired Student's *t* test; (**D**) Effects of siRNA for TLR2 on NF-κB and p38 pathway in HH4 cells. Cells (10^5^ cells/well) were pre-treated with 60 nM siRNA for TLR2 for 48 h. Then HH4 cells were treated with 5 mM FAC for 24 h and the protein expression levels of p-NF-κB, NF-κB, p-p38 and p38 using Western blot assay. +: in the presence of 5mM FAC, - : in the absence of 5mM FAC.](molecules-21-00322-g005){#molecules-21-00322-f005}
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###### 

Proteins differentially expressed in response to iron overload in HH4 cells.

  Ratio ^1^   Protein IDs   Protein Description                                                                          Gene Name   MW \[kDa\] ^2^
  ----------- ------------- -------------------------------------------------------------------------------------------- ----------- ----------------
  −1.781      Q92896        Golgi apparatus protein 1                                                                    GLG1        135
  −1.602      Q9NZN4        EH domain-containing protein 2                                                               EHD2        61
  −1.437      P09972        Fructose-bisphosphate aldolase C                                                             ALDOC       39
  −1.091      P42126        Isoform 2 of Enoyl-CoA delta isomerase 1, mitochondrial                                      ECI1        31
  −1.09       P07996        Thrombospondin-1                                                                             THBS1       129
  −0.983      P09603        Macrophage colony-stimulating factor 1                                                       CSF1        60
  −0.977      Q92522        Histone H1x                                                                                  H1FX        22
  −0.956      O95197        Isoform 3 of Reticulon-3                                                                     RTN3        26
  −0.927      P21399        Cytoplasmic aconitate hydratase                                                              ACO1        98
  −0.895      Q15418        Isoform 3 of Ribosomal protein S6 kinase α-1                                                 RPS6KA1     73
  −0.845      P07203        Glutathione peroxidase 1                                                                     GPX1        22
  −0.814      Q8TED1        Probable glutathione peroxidase 8                                                            GPX8        24
  −0.793      Q16678        Cytochrome P450 1B1                                                                          CYP1B1      61
  −0.768      Q6EMK4        Vasorin                                                                                      VASN        72
  −0.749      P51580        Thiopurine S-methyltransferase                                                               TPMT        28
  −0.745      Q969V3        Isoform 2 of Nicalin                                                                         NCLN        63
  −0.733      O00622        Protein CYR61                                                                                CYR61       42
  −0.729      P06865        β-Hexosaminidase                                                                             HEXA        58
  −0.7        P04179        Superoxide dismutase \[Mn\], mitochondrial                                                   SOD2        25
  −0.693      P17342        Isoform 2 of atrial natriuretic peptide receptor 3                                           NPR3        60
  −0.685      P07602        Proactivator polypeptide                                                                     PSAP        58
  −0.661      O43865        Putative adenosylhomocysteinase 2                                                            AHCYL1      59
  −0.657      P52630        Signal transducer and activator of transcription 2                                           STAT2       97
  −0.657      P51553        Isocitrate dehydrogenase \[NAD\] subunit gamma, mitochondrial                                IDH3G       43
  −0.648      P61970        Nuclear transport factor 2                                                                   NUTF2       14
  −0.647      Q9ULZ3        Apoptosis-associated speck-like protein containing a CARD (PYD and CARD domain containing)   PYCARD      22
  −0.639      P30626        Sorcin                                                                                       SRI         18
  −0.637      P0DMM9        Sulfotransferase 1A3                                                                         SULT1A3     34
  −0.617      Q9H845        Acyl-CoA dehydrogenase family member 9, mitochondrial                                        ACAD9       69
  −0.615      P53634        Dipeptidyl peptidase 1                                                                       CTSC        52
  −0.613      Q6P587        Acylpyruvase FAHD1, mitochondrial                                                            FAHD1       25
  −0.609      P16403        Histone H1.2                                                                                 HIST1H1C    21
  −0.602      P62805        Histone H4                                                                                   HIST1H4A    11
  −0.59       P04844        Isoform 2 of Dolichyl-diphosphooligosaccharide---protein glycosyltransferase subunit 2       RPN2        68
  −0.588      Q13228        Selenium-binding protein 1                                                                   SELENBP1    52
  0.586       P05362        Intercellular adhesion molecule 1                                                            ICAM1       58
  0.597       Q9Y6H1        Coiled-coil-helix-coiled-coil-helix domain-containing protein 2, mitochondrial               CHCHD2      16
  0.601       Q9Y371        Endophilin-B1                                                                                SH3GLB1     41
  0.61        P05161        Ubiquitin-like protein ISG15                                                                 ISG15       18
  0.614       P31689        DnaJ homolog subfamily A member 1                                                            DNAJA1      45
  0.614       P11387        DNA topoisomerase 1                                                                          TOP1        91
  0.621       P31153        S-adenosylmethionine synthase isoform type-2                                                 MAT2A       44
  0.636       Q14498        Isoform 3 of RNA-binding protein 39                                                          RBM39       57
  0.636       O75534        Isoform Short of Cold shock domain-containing protein E1                                     CSDE1       86
  0.643       P02786        Transferrin receptor protein 1                                                               TfR1        85
  0.653       O75976        Carboxypeptidase D                                                                           CPD         153
  0.656       Q9BQ52        Zinc phosphodiesterase ELAC protein 2                                                        ELAC2       92
  0.67        Q9UI12        ATPase, H^+^ transporting, lysosomal 50/57kDa, V1 subunit H, isoform CRA_c                   ATP6V1H     52
  0.678       P48729        Casein kinase 1, alpha 1, isoform CRA_g                                                      CSNK1A1     38
  0.681       P08473        Neprilysin                                                                                   MME         86
  0.685       Q9H2H9        Sodium-coupled neutral amino acid transporter 1                                              SLC38A1     54
  0.692       P08195        Isoform 2 of 4F2 cell-surface antigen heavy chain                                            SLC3A2      58
  0.702       Q9H5Q4        Dimethyladenosine transferase 2, mitochondrial                                               TFB2M       45
  0.712       P29317        Ephrin type-A receptor 2                                                                     EPHA2       108
  0.714       O14786        Neuropilin-1                                                                                 NRP1        101
  0.723       P11279        Lysosome-associated membrane glycoprotein 1                                                  LAMP1       39
  0.726       Q96PD2        Discoidin, CUB and LCCL domain-containing protein 2                                          DCBLD2      85
  0.747       P16070        CD44 antigen (Fragment)                                                                      CD44        20
  0.754       P46734        Dual specificity mitogen-activated protein kinase kinase 3                                   MAP2K3      39
  0.765       P08754        Guanine nucleotide-binding protein G(k) subunit alpha                                        GNAI3       41
  0.766       Q9H5V8        CUB domain-containing protein 1                                                              CDCP1       93
  0.777       Q13641        Trophoblast glycoprotein                                                                     TPBG        46
  0.809       P02795        Metallothionein-2                                                                            MT2A        6
  0.811       Q14978        Nucleolar and coiled-body phosphoprotein 1                                                   NOLC1       74
  0.825       P52926        High mobility group protein HMGI-C                                                           HMGA2       11
  0.833       P08962        CD63 antigen                                                                                 CD63        16
  0.837       P32455        Interferon-induced guanylate-binding protein 1                                               GBP1        68
  0.837       P04183        Thymidine kinase, cytosolic                                                                  TK1         25
  0.848       Q16831        Uridine phosphorylase 1                                                                      UPP1        34
  0.858       P21980        Protein-glutamine gamma-glutamyltransferase 2                                                TGM2        69
  0.875       P35080        Profilin-2                                                                                   PFN2        10
  0.882       P13726        Tissue factor                                                                                F3          33
  0.885       P56945        Breast cancer anti-estrogen resistance protein 1                                             BCAR1       93
  0.891       O15118        Niemann-Pick C1 protein                                                                      NPC1        142
  0.892       Q14669        E3 ubiquitin-protein ligase TRIP12                                                           TRIP12      220
  0.92        Q12996        Cleavage stimulation factor subunit 3                                                        CSTF3       83
  0.935       Q9H4A6        Golgi phosphoprotein 3                                                                       GOLPH3      34
  0.942       Q16850        Isoform 2 of lanosterol 14-α demethylase                                                     CYP51A1     46
  0.962       P11802        Cyclin-dependent kinase 4                                                                    CDK4        34
  0.97        Q9Y3E0        Vesicle transport protein GOT1B                                                              GOLT1B      14
  0.975       Q9Y3D8        Transcription initiation factor TFIID subunit 9                                              AK6         17
  0.983       Q9UBB6        Isoform 2 of neurochondrin                                                                   NCDN        77
  1.003       P17844        Probable ATP-dependent RNA helicase DDX5                                                     DDX5        107
  1.028       P05120        Plasminogen activator inhibitor 2                                                            SERPINB2    47
  1.085       P11234        Ras-related protein Ral-B                                                                    RALB        23
  1.127       Q96QD8        Sodium-coupled neutral amino acid transporter 2                                              SLC38A2     56
  1.162       P52292        Importin subunit alpha-1                                                                     KPNA2       58
  1.539       P40189        Interleukin-6 receptor subunit beta                                                          IL6ST       104
  1.54        Q06481        Amyloid-like protein 2                                                                       APLP2       76
  1.742       P05067        Gamma-secretase C-terminal fragment 59                                                       APP         81
  2.309       P09914        Interferon-induced protein with tetratricopeptide repeats 1                                  IFIT1       55
  2.408       P02787        Serotransferrin                                                                              TF          78
  2.809       O60603        Toll-like receptor 2                                                                         TLR2        90

^1^: LOG (FAC/Veh, 2); ^2^: MW: relative molecular mass (MW) generated by the MS system.
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###### 

Differentially expressed proteins involved in various iron overload-induced biological process in HH4 cells.

  Biological Process                                           Related Gene
  ------------------------------------------------------------ -----------------------------------------------------------------------------
  Response to wounding                                         CD44; F3; DCBLD2; GPX1; MAP2K3; NRP1; SERPINB2; SOD2; THBS1; TLR2; TF; TfR1
  Di-, tri-valent inorganic cation homeostasis                 ACO1; APP; APLP2; IL6ST; MT2A; SRI; SOD2; TF; TfR1; TGM2
  Regulation of growth                                         CD44; AK6; APP; CSF1; CYR61; DCBLD2; HMGA2; IDH3G; NRP1; BCAR1
  Positive regulation of signal transduction                   F3; CSF1; GPX1; GOLPH3; GOLT1B; IL6ST; THBS1; TGM2
  Anti-apoptosis                                               SH3GLB1; F3; GPX1; SERPINB2; SOD2; THBS1; TGM2
  Inflammatory response                                        CD44; F3; MAP2K3; THBS1; TLR2; TF; TfR1
  Positive regulation of cell migration                        F3; CSF1; ICAM1; IL6ST; BCAR1; THBS1
  Endocytosis                                                  ATP6V1H; EHD2; NPC1; APP; THBS1; TfR1
  Iron ion homeostasis                                         ACO1; SRI; SOD2; TF; TfR1
  Response to hypoxia                                          ALDOC; SOD2; THBS1; TF; TfR1
  Positive regulation of cytokine production                   PYCARD; IL6ST; THBS1; TLR2
  Apoptotic mitochondrial changes                              SH3GLB1; GPX1; SOD2
  Positive regulation of NF-κB transcription factor activity   PYCARD; ICAM1; TLR2
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###### 

Forward and reverse primer sequences, annealing temperature and product size for different genes.

  Gene       Primer                    Sequence (5'--3')         Product Size (bp)   Annealing Temperature (°C)
  ---------- ------------------------- ------------------------- ------------------- ----------------------------
  IL6ST      Forward                   GTGAGTGGGATGGTGGAAGG      78                  60
  Reverse    CAAACTTGTGTGTTGCCCATTC                                                  
  APP        Forward                   GCCCTGCGGAATTGACAAG       144                 60
  Reverse    CCATCTGCATAGTCTGTGTCTG                                                  
  TF         Forward                   GGTGGCAGAGTTCTATGGGTC     172                 60
  Reverse    ACAGTAAAGTAAGCCTATGGGGA                                                 
  TLR2       Forward                   ATCCTCCAATCAGGCTTCTCT     118                 60
  Reverse    GGACAGGTCAAGGCTTTTTACA                                                  
  MME        Forward                   GATCGCACTCTATGCAACCTAC    83                  60
  Reverse    TGTTTTGGATCAGTCGAGCAG                                                   
  TfR1       Forward                   ACCATTGTCATATACCCGGTTCA   219                 60
  Reverse    CAATAGCCCAAGTAGCCAATCAT                                                 
  CHCHD2     Forward                   ACACATTGGGTCACGCCATTA     201                 60
  Reverse    GCACCTCATTGAAACCCTCACA                                                  
  GLG1       Forward                   CCAAGATGACGGCCATCATTT     103                 60
  Reverse    AGCCGAATACTGCCACATTTC                                                   
  THBS1      Forward                   TGCTATCACAACGGAGTTCAGT    108                 60
  Reverse    GCAGGACACCTTTTTGCAGATG                                                  
  EHD2       Forward                   TCCGCAAACTCAACCCTTTC      78                  60
  Reverse    TCTCCAGGACCTGATTAGGGA                                                   
  CYP1B1     Forward                   ACGTACCGGCCACTATCACT      142                 60
  Reverse    CTCCCCACGACCTGATCCA                                                     
  TfR2       Forward                   AATGTCCTGAGTCAGAGCGG      141                 55.9
  Reverse    GGCAGACTCTACTGGAGCGA                                                    
  IL6        Forward                   CCAGAGCTGTGCAGATGAGT      99                  57.8
  Reverse    CATTTGTGGTTGGGTCAGG                                                     
  STAT3      Forward                   ACACACGGTACCTGGAGCAG      172                 57.8
  Reverse    TACTGCTGGTCAATCTCTCCC                                                   
  Ferritin   Forward                   ATCAACCTGGAGCTCTACGC      155                 57.8
  Reverse    TGGTTCTGCAGCTTCATCAG                                                    
  HAMP       Forward                   CTGTTTTCCCACAACAGAC       230                 59.8
  Reverse    CCTTCCTTATTTATTCCTGC                                                    
  β-actin    Forward                   CTTCCTGGGCATGGAGTC        232                 60
  Reverse    GCCGATCCACACGGAGTA                                                      

[^1]: These authors contributed equally to this work.
